| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1093/JNCI/82.2.96 |
| P698 | PubMed publication ID | 2403594 |
| P2093 | author name string | Von Hoff DD | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 96-101 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | He's not going to talk about in vitro predictive assays again, is he? | |
| P478 | volume | 82 |
| Q50761274 | A biochemical evaluation of oral squamous cell carcinoma growth by measurement of specific activity of succinate dehydrogenase in the subrenal capsule assay |
| Q35994671 | A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse |
| Q59139078 | A serum‐free medium for the courtenay‐mills soft agar assay |
| Q38186660 | Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing |
| Q54386796 | Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units. |
| Q68158836 | Activity of a recombinant transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units |
| Q54113258 | Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units. |
| Q40382300 | Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system |
| Q39912271 | Assay-based response evaluation in head and neck oncology: requirements for better decision making. |
| Q53462473 | Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma model. |
| Q41105196 | Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. |
| Q36821789 | Automated imaging and quantitation of tumor cells and CFU-GM colonies in microcapillary cultures: toward therapeutic index-based drug screening |
| Q68585689 | Basic principles in preclinical cancer chemotherapy |
| Q40689264 | Cellular drug resistance in childhood leukemia |
| Q36921714 | Chemosensitivity Testing: A Critical Review |
| Q54187511 | Chemosensitivity and chemoresistance assays: are they clinically relevant? |
| Q61051793 | Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma |
| Q39810212 | Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively |
| Q37641078 | Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer |
| Q37531356 | Correlation of histology and drug response of human tumors grown in native-state three-dimensional histoculture and in nude mice |
| Q44091565 | Extreme drug resistance in primary brain tumors: in vitro analysis of 64 resection specimens |
| Q26783599 | Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review |
| Q74811889 | Glutathione based approaches to improving cancer treatment |
| Q54113153 | Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer. |
| Q36810391 | In Vitro Evaluation of Chemotherapeutic Agents |
| Q50095965 | In vitro chemosensitivity of feline injection site-associated sarcoma cell lines to carboplatin. |
| Q55482458 | In vitro chemosensitivity test of human brain tumors using a three-dimensional organ culture with a collagen gel matrix. |
| Q70480031 | In vitro drug sensitivity testing for the individual patient: an ideal adjunct to current methods of treatment choice |
| Q34133637 | In vitro preclinical models for a rational design of chemotherapy combinations in human tumors |
| Q40384689 | Interferon treatment of human malignancies--a short review |
| Q45141048 | Investigation of HMN-176 anticancer activity in human tumor specimens in vitro and the effects of HMN-176 on differential gene expression |
| Q36135126 | Mathematical modelling of tumour response in primary breast cancer |
| Q44796372 | Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents |
| Q34680427 | Nuclear medicine imaging for prediction or early assessment of response to chemotherapy in patients suffering from breast carcinoma. |
| Q33491961 | Preclinical and phase I trials of topoisomerase I inhibitors |
| Q43938021 | Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers |
| Q50771001 | Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer. |
| Q48483676 | The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables |
| Q26861274 | The Valley of Death in anticancer drug development: a reassessment |
| Q40989319 | Tumor chemosensitivity and chemoresistance assays |
| Q36295130 | Use of the comet assay for assessment of drug resistance and its modulation in vivo |
| Q89362901 | [Preclinical models to establish innovative therapy strategies : Ex‑vivo assessment of head and neck tumor chemo- and immune responses] |
Search more.